TG Therapeutics TGTX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $461.9M+1,080% | $447.18M+1,812% | $447.47M— | $60.46M— | $39.15M— | ||
| $83K+76.6% | $59K-13.2% | $47K-51.5% | $41K-74.2% | $47K-72.7% | ||
| $69.65M+44.6% | $64.67M+52.0% | $60.97M+52.5% | $55.05M+47.2% | $48.17M+19.1% | ||
| —— | —— | —— | —— | —— | ||
| $240K+243% | $214K+376% | $168K+600% | $112K— | $70K— | ||
| —— | —— | —— | —— | —— | ||
| $185.11M+1,144% | $91.24M+942% | $97.85M+4,453% | $21.76M— | $14.88M— | ||
| —— | —— | —— | —— | —— | ||
| $306.14M+138% | -$90.79M-167% | -$90.79M-167% | $121.91M+21,439% | $128.49M+171% | ||
| $305.04M— | -$105.78M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TG Therapeutics generate?
- TG Therapeutics (TGTX) generated -$95.4M in operating cash flow over the trailing twelve months.
- What is TG Therapeutics's free cash flow?
- After $240.0K of capital expenditures, TG Therapeutics's free cash flow was -$95.6M over the trailing twelve months, down 66.2% year over year.
- Where does TG Therapeutics's cash flow data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
